Polycythemia in hepatits C seropositive end stage renal disease patients: Role of insulin like growth factor 1.
作者信息
Varma S
机构信息
Department of Nephrology, Sree Gokulam Medical College, Venjaramoodu, Thiruvananthapuram, Kerala, India.
出版信息
Indian J Nephrol. 2013 Jul;23(4):321-2. doi: 10.4103/0971-4065.114497.
Abstract
摘要
相似文献
1
Polycythemia in hepatits C seropositive end stage renal disease patients: Role of insulin like growth factor 1.丙型肝炎血清学阳性终末期肾病患者的红细胞增多症：胰岛素样生长因子1的作用
Indian J Nephrol. 2013 Jul;23(4):321-2. doi: 10.4103/0971-4065.114497.
2
Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis.胰岛素样生长因子I在终末期肾病和红细胞增多症患者的红细胞生成调节中发挥作用。
J Am Soc Nephrol. 1999 Feb;10(2):315-22. doi: 10.1681/ASN.V102315.
3
Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins.
Transplantation. 1998 Oct 27;66(8):1053-8. doi: 10.1097/00007890-199810270-00015.
4
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.甲状旁腺功能亢进症和肾性骨营养不良中的胰岛素样生长因子系统成分。
Kidney Int. 2000 Feb;57(2):423-36. doi: 10.1046/j.1523-1755.2000.00862.x.
5
Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.终末期肾病患儿的血清胰岛素样生长因子及其结合蛋白
Pediatr Nephrol. 1996 Jun;10(3):269-74. doi: 10.1007/BF00866755.
6
7
Polycythemia in pediatric renal transplantation.
Clin Nephrol. 1987 May;27(5):242-4.
8
Relative erythrocytosis of patients with end stage renal failure undergoing CAPD.
Ren Fail. 2002 Jan;24(1):29-35. doi: 10.1081/jdi-120002658.
9
The changes in serum type I and III procollagen, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with chronic renal failure.
J Trop Pediatr. 1996 Oct;42(5):271-5. doi: 10.1093/tropej/42.5.271.
10
Does Renal Tubular Injury-Induced Local Tissue Hypoxia Involve Post-Transplantation Erythrocytosis?肾小管损伤诱导的局部组织缺氧与移植后红细胞增多症有关吗？
Transplant Proc. 2017 Oct;49(8):1930-1934. doi: 10.1016/j.transproceed.2017.04.027.
本文引用的文献
1
Factors related to the absence of anemia in hemodialysis patients.与血液透析患者无贫血相关的因素。
Blood Purif. 2011;32(1):69-74. doi: 10.1159/000323095. Epub 2011 Feb 24.
2
Effect of hepatitis C infection on anemia in hemodialysis patients.丙型肝炎感染对血液透析患者贫血的影响。
Hemodial Int. 2008 Jan;12(1):94-9. doi: 10.1111/j.1542-4758.2008.00248.x.
3
Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.氯沙坦或依那普利对有或无移植后红细胞增多症患者血红蛋白、循环促红细胞生成素及胰岛素样生长因子-1的影响。
Am J Kidney Dis. 2002 Mar;39(3):600-8. doi: 10.1053/ajkd.2002.31404.
4
Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis.胰岛素样生长因子I在终末期肾病和红细胞增多症患者的红细胞生成调节中发挥作用。
J Am Soc Nephrol. 1999 Feb;10(2):315-22. doi: 10.1681/ASN.V102315.
5
Mechanism of the anemia of chronic renal failure.
Nephron. 1980;25(3):106-11. doi: 10.1159/000181764.
6
Erythropoiesis associated with viral hepatitis in end stage renal disease.
Am J Med Sci. 1984 Jan-Feb;287(1):56-8. doi: 10.1097/00000441-198401000-00017.
Zotero 插件